News | July 22, 2008

CardiArc SPECT Imaging System Up for Clinical Trials at Cleveland Clinic, Emory

July 23, 2008 - Independent research institutions will put the CardiArc SPECT system from CardiArc Inc, Southfield, MI, to the test. Both Cleveland Clinic, Cleveland, and Emory University, Atlanta, will evaluate the performance and design of the cardiovascular camera in clinical settings.

The unit is designed specifically for cardiac imaging, particularly for coronary artery disease detection. SPECT, or single photon emission computed tomography, noninvasively creates 3D images that show the blood flow and function of major organs, such as the heart.

The company said its main goal is looking for comparisons with regular patients on conventional types of SPECT imaging when looking for coronary artery disease. The research programs will explore how the CardiArc system stacks up to other SPECT systems.

Cleveland Clinic will compare the scans of 100 patients who will be scanned by both the CardiArc SPECT system and the facility’s current clinical SPECT machine. Researchers also will compile a database of CardiArc scans that show diseased hearts as well as normal hearts both at rest and under stress. Emory University will perform similar research with a pool of 200 patients.

For more information: www.cardiarc.com


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now